Leah Howard, Chief Operating Officer from the National Psoriasis Foundation or NPF, a non-profit organization that supports patients with psoriatic arthritis, discusses key information on the impact of this disease, the results of the PsA Narrative surveys, as well as ways that patients can work with their doctor to make sure their voice is heard. NPF is a collaborative partner with Pfizer on this initiative.
In this health supplier segment, Josh Blacher, Chief Business Officer at Inmed Pharmaceuticals, a biopharmaceutical company, discusses the potential that understudied cannabinoids can have in the medical space, as well as current trends in the industry.
Dr. Damon Reed, lead investigator for the National Pediatric Cancer Foundation’s (NPCF), research initiative called the Sunshine Project, discusses working with a consortium of 20 leading hospitals around the country to fast track less toxic, more targeted treatments for pediatric cancer.
The Crohn’s & Colitis Foundation and the Patient-Centered Outcomes Research Institute (PCORI) have a brand new clinical research study called DINE-CD. Dr. James Lewis is the primary investigator on the study and will talk about the latest research on IBD/Crohn’s Disease and how DINE-CD may change the way clinicians and patients view the role of diet in the treatment of IBD/Crohn’s. He is joined by Andrea Meyer, a Crohn’s disease patient and an active member of the study’s research team.
Ann Collett, mother of William, an 11-year-old with Acute Lymphoblastic Leukemia, talks about how the National Pediatric Cancer Foundation has helped give him hope.
Every year, experts gather for the world’s largest conference to share the latest advancements in treating diseases. Dr. Edward S. Kim, MD, Chair of the Department of Solid Tumor Oncology at Levine Cancer Institute, is here to discuss new data for unresectable Stage 3 non-small cell lung cancer.
Actress Cheryl Hines, known for her role in HBO’s “Curb Your Enthusiasm” and Dr. Marla Shapiro, Professor at the University of Toronto talk about the campaign “Painfully Awkward Conversation” that aims to empower women to have a conversation with their doctor, friends, partners about the very personal matter of painful sex during menopause.
Surgery is often a gateway to persistent opioid use. In this episode, Dr. Paul Sethi and Dr. Fred Muench share findings from the new Choices Matter Status Report, which examines opioid prescribing trends in the nation with a focus on the surgical setting.
Dr. Sean Ianchulev and Dr. Pamela Gallin discuss myopia and the positive results from its EYN PG21 proof-of-concept study demonstrating that its micro-dose of latanoprost successfully lowered intraocular pressure (IOP) and achieved patient usability.
David Frazer, CEO of the National Pediatric Cancer Foundation (NPCF), discusses pediatric cancer and the fight to find less toxic, more targeted treatments. Ten drugs have been developed for use in children with cancer since 1980 as compared to hundreds created for adults. He talks about the progress and goal of the company.